Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TMO · against 15 other Healthcare companies of similar size
Ranked #11 of 16 · scores higher than 33% of peers · safety percentile 22
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)5 peers with a safety percentile of 20–29, including TMO · Click a bar to see the companies
Mainly because of its debt / equity, current ratio and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | TMO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 14 reported | 0.81× | 0.77× | 46% | 33% | |
| BetaLower is better · 16 reported | 0.88 | 0.34 | 7% | 33% | |
| Current ratioHigher is better · 16 reported | 1.55× | 1.27× | 80% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 134.5B USD | 72 | 70 | |
| 2 | 155.7B USD | 43 | 64 | |
| 3 | 285.2B USD | 35 | 63 | |
| 4 | 177.5B USD | 33 | 71 | |
| 5 | 171.0B USD | 33 | 45 | |
| 7 | 302.7B USD | 31 | 63 | |
| 8 | 189.3B USD | 30 | 45 | |
| 9 | 317.9B CHF (≈$365.6B) | 25 | 60 | |
| 10 | 363.0B USD | 25 | 47 | |
| 11 | 258.2B USD | 22 | 47 | |
| 12 | 162.93T ARS (≈$162.9B) | 21 | 63 | |
| 13 | 356.9B USD | 19 | 37 | |
| 14 | 207.7B USD | 9 | 18 | |
| 15 | 505.4B USD | 9 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score